News for Healthier Living

Use of GLP-1RAs Tripled Among People Without Diabetes Between 2018 and 2022, Resulting in $5.8 Billion in Expenditures

An analysis of nationally representative survey data examined trends in glucagon-like peptide-1 receptor agonist (GLP-1RA) use and expenditure among people in the United States without diabetes.

March 31, 2025


April 2 2025

April 1 2025

March 31 2025

March 30 2025

March 29 2025

March 28 2025

March 27 2025

March 26 2025

March 25 2025

March 24 2025

March 23 2025

March 22 2025

March 21 2025

March 20 2025